You are here: All Products  > AstraZeneca/Merck PARP Inhibitor Approved in China for Ovarian Cancer

AstraZeneca/Merck PARP Inhibitor Approved in China for Ovarian Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products